Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathway

QR Code

Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathway

Thymoquinone (TQ), an active ingredient of Nigella sativa, has been reported to exhibit anti-oxidant, anti-inflammatory and anti-tumor activities through mechanism(s) that is not fully understood. In this study, we report the anticancer effects of TQ on breast cancer cells, and its potential effect...

Full description

Bibliographic Details
Main Authors:	Woo, C., Loo, S., Gee, V., Yap, C., Sethi, G., Kumar, Alan Prem, Benny Tan, K.
Format:	Journal Article
Published:	Elsevier 2011
Online Access:	http://hdl.handle.net/20.500.11937/50131

Similar Items

Thymoquinone: Potential cure for inflammatory disorders and cancer
by: Woo, C., et al.
Published: (2012)

PPARγ disease gene network and identification of therapeutic targets for prostate cancer
by: Venkatachalam, G., et al.
Published: (2011)

Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: The role of p38 MAPK and ROS
by: Woo, C., et al.
Published: (2013)

The Underlying molecular mechanism of bufei yishen prescription for copd in mice model based on NFR1/PPAR γ pathway
by: Xu, Cong
Published: (2024)

Elucidating hepatic lipidosis in stray cats through serum biochemistry, liver histopathology and liver RNA expression of PPAR-δ and PPAR-γ
by: F. Salleh,, et al.
Published: (2022)

γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: Potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent
by: Rajendran, P., et al.
Published: (2011)

PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers
by: Chen, L., et al.
Published: (2017)

Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model
by: Siveen, K., et al.
Published: (2014)

Evaluation of the PPAR-γ agonist pioglitazone in mild asthma: a double-blind randomized controlled trial
by: Anderson, J.R., et al.
Published: (2016)

γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model
by: Siveen, K., et al.
Published: (2014)

Role Of Peroxisome Proliferator Activated Receptor-γ ( PPARγ) Ligands On The Foam Cell Formation Derived From MNV-1 Infected Macrophages
by: Musa, Khirun
Published: (2017)

Omega 3 polyunsaturated fatty acid improves spatial learning and hippocampal Peroxisome Proliferator Activated Receptors (PPARα and PPARγ) gene expression in rats
by: Hajjar, Toktam, et al.
Published: (2012)

Osteoporosis: possible pathways involved and the role of natural phytoestrogens in bone metabolism
by: Zar, Chi Thent, et al.
Published: (2019)

Evaluation of the PPAR-γ agonist pioglitazone in mild asthma: a double-blind randomized controlled trial
by: Leroyer, Christophe, et al.
Published: (2016)

Xanthones from Garcinia Malaccencis improve Glut4 aswell as decreased Pparγ activation on adipocytes
by: Bakhtiar, M. Taher, et al.
Published: (2013)

Haemodynamic Effects Of Adiponectin On PPAR–γ Receptors In Diabetic And Nondiabetic Wistar Kyoto And Spontaneously Hypertensive Rats
by: Afzal, Sheryar
Published: (2017)

Ciglitazone inhibits growth and induces apoptosis in human colorectal cancer cell lines independently of PPARγ
by: Darus, Halisa Mohd, et al.
Published: (2004)

Identification of novel peroxisome proliferator-activated receptor-gamma (PPAR[gamma]) agonists using molecular modeling method
by: Kumar, Alan Prem
Published: (2014)

First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway
by: Manu, K., et al.
Published: (2012)

Stochastic modelling of cancer cell proliferation and death in response to anticancer therapeutics of thymoquinone
by: Shabana, Tabassum
Published: (2023)

Stochastic modelling of the oral cancer proliferation and death in the presence of Thymoquinone as anticancer therapeutics
by: Tabassum, Shabana, et al.
Published: (2021)

Antiobesity effects of α-mangostin through glut4 and leptin expression together with pparγ activation in adipocytes
by: Bakhtiar, M. Taher, et al.
Published: (2013)

Molecular characterization of peroxisome proliferator activated receptor gamma2 (PPARγ2) promoter from bovine
by: Ismail, Ida Shazrina, et al.
Published: (2004)

Molecular characterization of peroxisome proliferator activated receptor gamma2 (PPARγ2) promoter from bovine
by: Ismail, Ida Shazrina, et al.
Published: (2004)

Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis
by: Shanmugam, M., et al.
Published: (2018)

Parameter estimation of the stochastic model for oral cancer in response to thymoquinone (TQ) as anticancer therapeutics
by: Tabassum, Shabana, et al.
Published: (2021)

Acrylated vegetable oil nanoparticle as a carrier and controlled release of the anticancer drug-thymoquinone
by: Tajau, Rida, et al.

Virtual screening of pyrazole derivatives of usnic acid as new class of anti-hyperglycemic agents against PPARγ agonists
by: Roney, Miah, et al.
Published: (2023)

In silico identification of PPARγ agonists from diffractaic acid analogs in prostate cancer: a comprehensive computational approach
by: Roney, Miah, et al.
Published: (2025)

Perfluorooctane sulfonate induces neuronal and oligodendrocytic differentiation in neural stem cells and alters the expression of PPARγ in vitro and in vivo
by: Wan Ibrahim, Wan Norhamidah, et al.
Published: (2013)

Synthesis, biological evaluation and in silico and in vitro mode-of-action analysis of novel dihydropyrimidones targeting PPAR-y
by: Bharathkumar, H., et al.
Published: (2014)

Homology Modeling and Molecular Docking Studies on Type II Diabetes Complications Reduced PPARγ Receptor with Various Ligand Molecules
by: Prabhu, S., et al.
Published: (2017)

Synergism between cAMP and PPARγ signalling in the initiation of UCP1 gene expression in HIB1B brown adipocytes
by: Chen, H.Y., et al.
Published: (2013)

Vitamin D3-associated lyotropic liquid crystalline nanoparticles for gemcitabine and thymoquinone delivery for treatment of luminal breast cancer with resistant characteristics
by: Loo, Yan Shan
Published: (2023)

The Effect Of Peroxisome Proliferatorr Activated Receptor Gamma (Pparγ) On The Expression Of Foxp3, Tigit, Icos And Histone Proteins In Natural T-Regulatory Cells
by: Lee, Pei Chen
Published: (2019)

Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn
by: Shanmugam, M., et al.
Published: (2018)

Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn
by: Shanmugam, M., et al.
Published: (2017)

Association Of Peroxisome Proliferator-Activated Receptors (Ppars) Α, Γ And Δ Gene Polymorphisms With Obesity And Metabolic Syndrome In The Sub-Urban Kampar Population, Malaysia
by: Phee, Chia Phee
Published: (2015)

Toxicity and anti-breast cancer properties of thymoquinone-loaded nanostructured lipid carrier in mice
by: Ong, Yong Sze
Published: (2019)

The expression of PPARS gamma in the cervical cancer line, hela and the effects of specific PPAR ligand on cell growth
by: Yaacob, Nik Soriani
Published: (2013)

Cannot write session to /tmp/vufind_sessions/sess_393v41k2gcctluvhkguusecknc